Commonwealth Bank of Australia boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,626 shares of the medical instruments supplier’s stock after purchasing an additional 260 shares during the quarter. Commonwealth Bank of Australia’s holdings in DENTSPLY SIRONA were worth $104,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of XRAY. BlackRock Inc. increased its holdings in DENTSPLY SIRONA by 3,103.7% during the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after purchasing an additional 13,457,730 shares during the last quarter. Principal Financial Group Inc. increased its holdings in DENTSPLY SIRONA by 1,445.2% during the 1st quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after purchasing an additional 4,950,337 shares during the last quarter. Clearbridge Investments LLC increased its holdings in DENTSPLY SIRONA by 34.6% during the 1st quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after purchasing an additional 1,353,040 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $64,184,000. Finally, Renaissance Technologies LLC increased its holdings in DENTSPLY SIRONA by 246.0% during the 1st quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after purchasing an additional 742,700 shares during the last quarter. Institutional investors own 93.87% of the company’s stock.

DENTSPLY SIRONA Inc. (XRAY) opened at 58.65 on Thursday. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68. The firm’s market cap is $13.46 billion. The stock has a 50 day moving average price of $56.98 and a 200 day moving average price of $61.67.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the consensus estimate of $0.65. The firm had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.60%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

WARNING: “Commonwealth Bank of Australia Has $104,000 Holdings in DENTSPLY SIRONA Inc. (XRAY)” was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.watchlistnews.com/commonwealth-bank-of-australia-has-104000-holdings-in-dentsply-sirona-inc-xray/1577405.html.

XRAY has been the topic of several analyst reports. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective on the stock. Credit Suisse Group restated an “outperform” rating and set a $75.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective on the stock in a report on Thursday, July 13th. Finally, Stifel Nicolaus restated a “buy” rating and set a $66.00 price objective (down from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $65.73.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.